Martin Luther King, JR. - Los Angeles (Mlk-La) Healthcare Corporation

Martin Luther King, JR. - Los Angeles (Mlk-La) Healthcare Corporation was paid $83.68M by Medicaid between Jan 2018 and Dec 2024, across 296 billing codes. Its largest line is 0450, Emergency room services — 18% of everything it billed.

33Billing provider infoMARTIN LUTHER KING, JR. - LOS ANGELES (MLK-LA) HEALTHCARE CORPORATION
LOS ANGELES, CA 90059

33aNPI1114367497assigned 07/01/2013

33bProvider typeGeneral Acute Care Hospital

28Total paid$83.68M

24GClaims3,515,779

24DCodes billed296

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#30 of 410

Median peer was paid$6.90M

This provider vs. median12×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	471,408	$8.76M
2019	403,099	$14.22M
2020	336,001	$6.04M
2021	384,201	$7.71M
2022	510,788	$11.09M
2023	762,865	$17.13M
2024incomplete	647,417	$18.74M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
0450	Emergency room services	18%	294,228	254,117	$14.80M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	5.6%	94,333	84,782	$4.68M
99281	Emergency department visit for the evaluation and management, self-limited or minor	5.0%	28,217	23,278	$4.18M
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	4.0%	36,825	34,628	$3.34M
85025	Blood count; complete (CBC), automated, and automated differential WBC count	3.6%	208,298	176,925	$3.05M
70450	Computed tomography, head or brain; without contrast material	3.3%	26,560	24,855	$2.74M
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	3.2%	103,774	92,984	$2.64M
96375	Therapeutic injection; each additional sequential IV push	3.0%	72,596	64,078	$2.54M
Z7502		2.9%	63,986	63,601	$2.46M
74160		2.3%	10,607	9,818	$1.92M
74177	Computed tomography, abdomen and pelvis; with contrast material	2.2%	8,300	7,997	$1.82M
0762		2.1%	14,260	7,355	$1.76M

284 more codes

85610		2.0%	135,333	$1.67M
80048	Basic metabolic panel (calcium, ionized)	1.9%	207,976	$1.63M
96361	Intravenous infusion, hydration; each additional hour	1.8%	74,181	$1.51M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	1.8%	29,683	$1.47M
99285	Emergency room visit (most serious)	1.5%	5,981	$1.28M
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	1.3%	41,301	$1.10M
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	1.2%	19,437	$1.02M
71275	Computed tomographic angiography, chest, with contrast material	1.1%	4,944	$936K
74176	Computed tomography, abdomen and pelvis; without contrast material	1.1%	7,713	$925K
80076		1.1%	137,445	$912K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	1.1%	18,514	$903K
71045	Radiologic examination, chest; single view	1.1%	78,796	$897K
83880		1.1%	34,543	$893K
83690		<1%	118,730	$836K
0301		<1%	10,774	$802K
0250		<1%	168,874	$796K
84484		<1%	65,840	$757K
J7030	Infusion, normal saline solution , 1000 cc	<1%	94,998	$667K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	14,079	$657K
99199	Unlisted special service, procedure or report	<1%	15,898	$650K
Z7610		<1%	53,743	$589K
0160		<1%	5,713	$577K
72125	Computed tomography, cervical spine; without contrast material	<1%	3,413	$543K
99284	Emergency room visit (serious)	<1%	6,400	$513K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	75,167	$491K
71046	Radiologic examination, chest; 2 views	<1%	22,480	$477K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	5,965	$459K
74150		<1%	3,512	$434K
93971		<1%	4,129	$421K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	7,289	$416K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	6,956	$393K
76801		<1%	7,322	$391K
76830	Ultrasound, transvaginal	<1%	6,117	$386K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	51,008	$379K
0119		<1%	287	$363K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	46,687	$341K
70486		<1%	2,577	$334K
93970		<1%	2,036	$329K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	11,605	$323K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	11,668	$322K
J3490	Unclassified drugs	<1%	78,573	$310K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	6,770	$307K
87086	Culture, bacterial; quantitative colony count, urine	<1%	49,992	$302K
84702		<1%	29,926	$296K
99283	Emergency room visit (moderate)	<1%	4,706	$288K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	13,131	$272K
81001		<1%	78,764	$262K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	1,525	$237K
82947		<1%	33,986	$236K
0270		<1%	63,554	$212K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	1,006	$202K
87040		<1%	11,893	$175K
72100		<1%	5,360	$162K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	2,751	$162K
73630		<1%	6,083	$153K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	3,335	$148K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	26,371	$147K
96376		<1%	5,933	$135K
73610		<1%	5,212	$126K
73130		<1%	4,819	$125K
0761		<1%	4,505	$125K
83605		<1%	12,486	$121K
73562		<1%	4,728	$120K
73030		<1%	5,093	$117K
36415	Collection of venous blood by venipuncture	<1%	79,063	$113K
85730		<1%	17,358	$104K
83036	Hemoglobin; glycosylated (A1C)	<1%	6,760	$95K
70496		<1%	543	$94K
J1815	Injection, insulin, per 5 units	<1%	11,661	$93K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	3,044	$92K
87631		<1%	2,191	$91K
90715		<1%	2,977	$90K
87186		<1%	12,414	$89K
72131		<1%	691	$85K
73564		<1%	2,446	$83K
73110		<1%	2,842	$83K
85379		<1%	8,372	$77K
10060		<1%	1,888	$77K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	487	$73K
J1170	Injection, hydromorphone, up to 4 mg	<1%	10,083	$71K
0420		<1%	1,690	$70K
81003		<1%	28,861	$69K
70491		<1%	451	$69K
82803		<1%	4,625	$66K
73502		<1%	2,391	$65K
80305		<1%	5,678	$63K
80053	Comprehensive metabolic panel	<1%	6,486	$63K
73590		<1%	2,642	$63K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	4,646	$63K
74022		<1%	1,776	$63K
73080		<1%	2,094	$60K
74018		<1%	3,214	$60K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	11,064	$59K
83735		<1%	8,985	$59K
76870		<1%	1,320	$58K
J2060	Injection, lorazepam, 2 mg	<1%	10,099	$57K
J2274	Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg	<1%	3,560	$52K
70498		<1%	348	$51K
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	678	$50K
94644		<1%	2,624	$45K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	23,554	$44K
87077		<1%	6,488	$41K
73140		<1%	2,078	$40K
J1644	Injection, heparin sodium, per 1000 units	<1%	3,102	$40K
84443	Thyroid stimulating hormone (TSH)	<1%	3,084	$38K
80061	Lipid panel	<1%	4,487	$37K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	1,143	$36K
72040		<1%	1,364	$35K
86900		<1%	3,075	$34K
82550		<1%	6,098	$33K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	1,364	$32K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	3,383	$32K
73090		<1%	1,683	$32K
J1630	Injection, haloperidol, up to 5 mg	<1%	5,371	$31K
12002		<1%	446	$30K
86850		<1%	6,827	$30K
J3370	Injection, vancomycin hcl, 500 mg	<1%	2,064	$28K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	5,495	$26K
99221		<1%	421	$26K
86140		<1%	5,283	$25K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	1,934	$24K
97802		<1%	397	$23K
71250		<1%	176	$22K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	213	$22K
12001		<1%	168	$22K
84100		<1%	4,028	$21K
87210		<1%	6,208	$21K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	2,640	$21K
86901		<1%	7,059	$20K
G0378	Hospital observation service, per hour	<1%	102	$20K
87070		<1%	3,056	$20K
29125		<1%	623	$19K
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	2,176	$19K
76770		<1%	270	$18K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	451	$18K
59025	Fetal non-stress test	<1%	1,643	$17K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	4,783	$17K
Z9725		<1%	384	$17K
85652		<1%	7,359	$16K
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	2,992	$16K
J1953	Injection, levetiracetam, 10 mg	<1%	1,699	$16K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	4,024	$16K
J1940	Injection, furosemide, up to 20 mg	<1%	3,610	$15K
70480		<1%	109	$15K
80074		<1%	360	$15K
29515		<1%	465	$15K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	3,027	$14K
96367		<1%	477	$14K
70547		<1%	114	$14K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	1,369	$13K
J1171	Injection, hydromorphone, 0.1 mg	<1%	287	$13K
59050		<1%	2,051	$13K
70544		<1%	123	$12K
72070		<1%	472	$12K
0760		<1%	626	$12K
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	6,244	$12K
A4649	Surgical supply; miscellaneous	<1%	12,140	$12K
73552		<1%	548	$11K
99499		<1%	38	$11K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	205	$11K
93880		<1%	84	$11K
73060		<1%	435	$10K
97750		<1%	268	$9K
97161		<1%	219	$9K
81025		<1%	1,850	$8K
90686		<1%	561	$8K
87184		<1%	1,600	$8K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	1,543	$8K
0324		<1%	698	$7K
99070		<1%	3,518	$7K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	1,563	$7K
73660		<1%	448	$7K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	303	$7K
J1741	Injection, ibuprofen, 100 mg	<1%	631	$7K
84145		<1%	409	$7K
J0461	Injection, atropine sulfate, 0.01 mg	<1%	863	$7K
84439		<1%	882	$6K
70360		<1%	218	$6K
80185		<1%	542	$6K
70487		<1%	47	$6K
82805		<1%	176	$6K
73700		<1%	49	$6K
C9113	Injection, pantoprazole sodium, per vial	<1%	1,018	$5K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	611	$5K
J3480	Injection, potassium chloride, per 2 meq	<1%	300	$4K
71101		<1%	154	$4K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	696	$4K
76641		<1%	67	$4K
71020		<1%	191	$4K
76819	Fetal biophysical profile; without non-stress testing	<1%	110	$3K
82140		<1%	318	$3K
84481		<1%	276	$3K
A9270	Non-covered item or service	<1%	1,679	$3K
J2358	Injection, olanzapine, long-acting, 1 mg	<1%	72	$3K
0636		<1%	1,584	$3K
71010		<1%	325	$3K
82728		<1%	303	$3K
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	1,108	$3K
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	265	$3K
J1956	Injection, levofloxacin, 250 mg	<1%	98	$3K
72128		<1%	13	$2K
86701		<1%	288	$2K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	193	$2K
72192		<1%	13	$2K
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	368	$2K
J2550	Injection, promethazine hcl, up to 50 mg	<1%	278	$2K
Z7500		<1%	51	$2K
93000		<1%	56	$2K
12011		<1%	49	$2K
83615		<1%	333	$2K
70490		<1%	14	$2K
J7050	Infusion, normal saline solution, 250 cc	<1%	447	$2K
J3360	Injection, diazepam, up to 5 mg	<1%	107	$1K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	12	$1K
J0456	Injection, azithromycin, 500 mg	<1%	294	$1K
J8540	Dexamethasone, oral, 0.25 mg	<1%	554	$1K
86592		<1%	421	$1K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	103	$1K
A0429	Emergency ambulance ride, basic life support	<1%	34	$1K
J1165	Injection, phenytoin sodium, per 50 mg	<1%	109	$1K
87081		<1%	374	$1K
87205		<1%	410	$1K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	40	$1K
90656		<1%	30	$970.18
90935	Hemodialysis procedure with single evaluation by a physician	<1%	38	$839.56
J7510	Prednisolone oral, per 5 mg	<1%	160	$797.59
27502		<1%	12	$787.19
J2470	Injection, pantoprazole sodium, 40 mg	<1%	176	$745.45
85007		<1%	854	$685.94
86922		<1%	25	$662.76
84550		<1%	146	$652.57
90714		<1%	60	$652.56
94664		<1%	94	$639.29
73000		<1%	25	$619.43
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	88	$494.69
86308		<1%	129	$410.44
97162		<1%	15	$388.27
72170		<1%	32	$380.33
87181		<1%	301	$358.90
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	56	$333.15
92558		<1%	115	$330.05
0430		<1%	15	$321.44
Q2039	Influenza virus vaccine, not otherwise specified	<1%	18	$316.04
J3410	Injection, hydroxyzine hcl, up to 25 mg	<1%	28	$303.84
73560		<1%	14	$284.43
36600		<1%	35	$271.86
85044		<1%	78	$263.10
87169		<1%	97	$238.20
0320		<1%	49	$229.52
0300		<1%	422	$226.99
85027		<1%	59	$223.62
84478		<1%	43	$198.25
83540		<1%	42	$190.26
82746		<1%	25	$173.81
S0119	Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code)	<1%	57	$167.48
J0690	Injection, cefazolin sodium, 500 mg	<1%	49	$133.66
10061		<1%	14	$120.00
0259		<1%	71	$114.40
86593		<1%	21	$90.24
99072		<1%	253	$73.47
0310		<1%	316	$49.60
0410		<1%	13	$49.10
85651		<1%	22	$46.11
0730		<1%	204	$29.84
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	59	$8.35
Q9963	High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml	<1%	14	$3.80
0307		0%	141	$0.00
99214	Doctor's office visit, returning patient (more involved)	0%	92	$0.00
0306		0%	191	$0.00
0305		0%	29	$0.00
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	0%	91	$0.00
S9445	Patient education, not otherwise classified, non-physician provider, individual, per session	0%	429	$0.00
20553		0%	159	$0.00
0949		0%	27	$0.00
Q4051	Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies)	0%	44	$0.00
99213	Doctor's office visit, returning patient (routine)	0%	129	$0.00
0258		0%	26	$0.00
0302		0%	68	$0.00
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	0%	24	$0.00
Q0144	Azithromycin dihydrate, oral, capsules/powder, 1 gram	0%	84	$0.00
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	0%	62	$0.00
0402		0%	15	$0.00
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	0%	27	$0.00
72275		0%	12	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBATCHLOR, ELAINE (CEO)